natgillin/translations-raw huggingface dataset:
When the company resulting from the cross-border merger is operating under an employee participation system, that company shall be obliged to take measures to ensure that employees’ participation rights are protected in the event of subsequent domestic mergers for a period of three years after the cross-border merger has taken effect, by applying mutatis mutandis the rules laid down in this Article.
Kadar družba, ki nastane s čezmejno združitvijo, deluje po sistemu soodločanja delavcev, je ta družba dolžna sprejeti ukrepe za zagotovitev, da so pravice do udeležbe delavcev v primeru naknadnih nacionalnih združitev v roku treh let po začetku veljavnosti čezmejne združitve zaščitene s smiselno uporabo pravila iz tega člena.
A cross-border merger which has taken effect as provided for in Article 12 may not be declared null and void.
Čezmejna združitev, ki je začela veljati v skladu s členom 12, ne more biti razglašena za nično.
Five years after the date laid down in the first paragraph of Article 19, the Commission shall review this Directive in the light of the experience acquired in applying it and, if necessary, propose its amendment.
Pet let od dne iz prvega odstavka člena 19 Komisija ponovno pregleda to direktivo na podlagi izkušenj, pridobljenih pri njeni uporabi, in, če je to potrebno, predlaga njene spremembe.
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 15 December 2007.
Države članice sprejmejo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 15 decembra 2007.
Done at Strasbourg, 26 October 2005.
V Strasbourgu, 26. oktobra 2005
OJ C 117, 30.4.2004, p. 43.
UL C 117, 30.4.2004, str. 43.
Opinion of the European Parliament of 10 May 2005 (not yet published in the Official Journal) and Council Decision of 19 September 2005.
Mnenje Evropskega parlamenta z dne 10. maja 2005 (še ni objavljeno v Uradnem listu) in Sklep Sveta z dne 19. septembra 2005.
Council Regulation (EC) No 139/2004 of 20 January 2004 on the control of concentrations between undertakings (the EC Merger Regulation) (OJ L 24, 29.1.2004, p. 1).
Uredba Sveta (ES) št. 139/2004 z dne 20. januarja 2004 o nadzoru koncentracij podjetij (Uredba ES o združitvah) (UL L 24, 29.1.2004, str. 1).
OJ L 225, 12.8.1998, p. 16.
UL L 225, 12.8.1998, str. 16.
OJ L 82, 22.3.2001, p. 16.
UL L 82, 22.3.2001, str. 16.
OJ L 80, 23.3.2002, p. 29.
UL L 80, 23.3.2002, str. 29.
Directive as amended by Directive 97/74/EC (OJ L 10, 16.1.1998, p. 22).
Direktiva, kakor je bila spremenjena z Direktivo 97/74/ES (UL L 10, 16.1.1998, str. 22).
Regulation as amended by Regulation (EC) No 885/2004 (OJ L 168, 1.5.2004, p. 1).
Uredba, kakor je bila spremenjena z Uredbo (ES) št. 885/2004 (UL L 168, 1.5.2004, str. 1).
First Council Directive 68/151/EEC of 9 March 1968 on coordination of safeguards which, for the protection of the interests of members and others, are required by Member States of companies within the meaning of the second paragraph of Article 58 of the Treaty, with a view to making such safeguards equivalent throughout the Community (OJ L 65, 14.3.1968, p. 8).
Prva direktiva Sveta 68/151/EGS z dne 9. marca 1968 o uskladitvi zaščitnih ukrepov za varovanje interesov družbenikov in tretjih oseb, ki jih države članice zahtevajo od gospodarskih družb v skladu z drugim odstavkom člena 58 Pogodbe, zato da se oblikujejo zaščitni ukrepi z enakim učinkom v vsej Skupnosti (UL L 65, 14.3.1968, str. 8).
OJ L 295, 20.10.1978, p. 36.
UL L 295, 20.10.1978, str. 36.
Having regard to the Treaty establishing the European Community, and in particular Article 44 thereof, Having regard to the proposal from the Commission,
ob upoštevanju Pogodbe o ustanovitvi Evropske skupnosti in zlasti člena 44 Pogodbe,
Commission Directive 2005/57/EC
Direktiva Komisije 2005/57/ES
of 21 September 2005
z dne 21. septembra 2005
amending Council Directive 91/414/EEC to include MCPA and MCPB as active substances
o spremembi Direktive Sveta 91/414/EGS glede vključitve MCPA in MCPB med aktivne snovi
Commission Regulation (EEC) No 3600/92 of 11 December 1992 laying down the detailed rules for the implementation of the first stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC concerning the placing of plant protection products on the market [2] establishes a list of active substances to be assessed, with a view to their possible inclusion in Annex I to Directive 91/414/EEC.
Uredba Komisije (EGS) št. 3600/92 z dne 11. decembra 1992 o določitvi podrobnih pravil za izvajanje prve faze delovnega programa iz člena 8(2) Direktive Sveta 91/414/EGS o dajanju fitofarmacevtskih sredstev v promet [2] določa seznam aktivnih snovi, ki jih je treba oceniti zaradi njihove možne vključitve v Prilogo I k Direktivi 91/414/EGS.
That list includes MCPA and MCPB.
Navedeni seznam vključuje MCPA in MCPB.
For those active substances the effects on human health and the environment have been assessed in accordance with the provisions laid down in Regulation (EEC) No 3600/92 for a range of uses proposed by the notifiers.
Vplivi navedenih aktivnih snovi na zdravje ljudi in okolje so se ocenjevali v skladu z določbami iz Uredbe (EGS) št. 3600/92 za vrste uporabe, ki so jih predlagali prijavitelji.
By Commission Regulation (EC) No 933/94 of 27 April 1994 laying down the active substances of plant protection products and designating the rapporteur Member State for the implementation of Regulation (EEC) No 3600/92 [3], Italy was designated as rapporteur Member State.
Z Uredbo Komisije (ES) št. 933/94 z dne 27. aprila 1994 o določitvi aktivnih snovi fitofarmacevtskih sredstev in imenovanju držav članic poročevalk za izvajanje Uredbe (EGS) št. 3600/92 [3] je bila Italija imenovana za državo članico poročevalko.
On 5 April 2001 and 19 December 2001 Italy submitted the relevant assessment reports and recommendations to the Commission in accordance with Article 7(1)(c) of Regulation (EEC) No 3600/92.
aprila 2001 in 19. decembra 2001 je Italija predložila Komisiji ustrezna poročila o oceni in priporočila v skladu s členom 7(1)(c) Uredbe (EGS) št. 3600/92.
The assessment reports have been reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health.
Poročila o oceni so države članice in Komisija pregledale v Stalnem odboru za prehransko verigo in zdravstveno varstvo živali.
The reviews were finalised on 15 April 2005 in the format of the Commission review reports for MCPA and MCPB.
Pregledi so bili končani 15. aprila 2005 v obliki poročil Komisije o pregledu za MCPA in MCPB.
The reviews of MCPA and MCPB did not reveal any open question to be addressed by the Scientific Committee on Plants or the European Food Safety Authority (EFSA) which has taken over the role of the latter.
Pri pregledu MCPA in MCPB se ni razkrilo nobeno odprto vprašanje, ki bi ga bilo treba nasloviti na Znanstveni odbor za rastline ali Evropsko agencijo za varnost hrane (EFSA), ki je prevzela vlogo prvega.
It has appeared from the various examinations made that plant protection products containing MCPA or MCPB may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review reports.
Različne opravljene preiskave so pokazale, da je za fitofarmacevtska sredstva, ki vsebujejo MCPA ali MCPB, možno pričakovati, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS, zlasti v zvezi z uporabami, ki so bile proučene in podrobno navedene v poročilih Komisije o pregledu.
It is therefore appropriate to include these active substances in Annex I, in order to ensure that in all Member States the authorisations of plant protection products containing these active substances can be granted in accordance with the provisions of that Directive.
Primerno je torej vključiti te aktivne snovi v Prilogo I zato, da se lahko v vseh državah članicah odobri registracija fitofarmacevtskih sredstev, ki vsebujejo te aktivne snovi, v skladu z določbami navedene direktive.
Without prejudice to the obligations defined by Directive 91/414 as a consequence of including an active substance in Annex I, Member States should be allowed a period of six months after inclusion to review existing authorisations of plant protection products containing MCPA or MCPB to ensure that the requirements laid down by Directive 91/414/EEC, in particular in its Article 13 and the relevant conditions set out in Annex I, are satisfied. Member States should vary, replace or withdraw, as appropriate, existing authorisations in accordance with the provisions of Directive 91/414/EEC.
Brez poseganja v obveznosti, opredeljene v Direktivi 91/414/EGS kot posledica vključitve aktivne snovi v Prilogo I, je treba dovoliti državam članicam, da v roku šestih mesecev po vključitvi pregledajo obstoječe registracije za fitofarmacevtska sredstva, ki vsebujejo MCPA ali MCPB, da se zagotovi izpolnjevanje zahtev iz Direktive 91/414/EGS, zlasti iz člena 13 in ustreznih pogojev iz Priloge I. Države članice spremenijo, zamenjajo ali prekličejo, če je primerno, obstoječe registracije v skladu z določbami Direktive 91/414/EGS.
By derogation from the above deadline, a longer period should be provided for the submission and assessment of the complete Annex III dossier of each plant protection product for each intended use in accordance with the uniform principles laid down in Directive 91/414/EEC.
Z odstopanjem od zgoraj določenega roka je treba predvideti daljše obdobje za predložitev in oceno celotne dokumentacije iz Priloge III vsakega fitofarmacevtskega sredstva za vsako nameravano uporabo, kakor je v skladu z enotnimi načeli iz Direktive 91/414/EGS.
The experience gained from previous inclusions in Annex I to Directive 91/414/EEC of active substances assessed in the framework of Regulation (EEC) No 3600/92 has shown that difficulties can arise in interpreting the duties of holders of existing authorisations in relation to access to data.
Izkušnje, pridobljene iz prejšnjih vključitev v Prilogo I k Direktivi 91/414/EGS o aktivnih snoveh, ocenjenih v okviru Uredbe (EGS) št. 3600/92, so pokazale, da težave lahko izhajajo iz razlaganja dolžnosti imetnikov obstoječih registracij v zvezi z dostopom do podatkov.
In order to avoid further difficulties it therefore appears necessary to clarify the duties of the Member States, especially the duty to verify that the holder of an authorisation demonstrates access to a dossier satisfying the requirements of Annex II to that Directive.
Da bi se izognili nadaljnjim težavam, je treba razjasniti dolžnosti držav članic, zlasti dolžnost preveriti, da imetnik registracije dokaže dostop do dokumentacije, ki izpolnjuje zahteve Priloge II k navedeni direktivi.
However, this clarification does not impose any new obligations on Member States or holders of authorisations compared to the directives which have been adopted until now amending Annex I.
Vendar to pojasnilo v primerjavi z direktivami, ki so bile do zdaj sprejete o spremembi Priloge I, ne nalaga novih obveznosti državam članicam ali imetnikom registracije.
The measures provided for in this Directive are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
Ukrepi, predvideni s to direktivo, so v skladu z mnenjem Stalnega odbora za prehransko verigo in zdravje živali –
Annex I to Directive 91/414/EEC is amended as set out in the Annex to this Directive.
Priloga I k Direktivi 91/414/EGS se spremeni, kakor je navedeno v Prilogi k tej direktivi.
Member States shall adopt and publish by 31 October 2006 at the latest the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice najpozneje do 31. oktobra 2006 sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo.
They shall apply those provisions from 1 November 2006.
Te predpise začnejo uporabljati od 1. novembra 2006.
Member States shall in accordance with Directive 91/414/EEC, where necessary, amend or withdraw existing authorisations for plant protection products containing MCPA or MCPB as active substances by 31 October 2006.
Države članice do 31. oktobra 2006 v skladu z Direktivo 91/414/EGS spremenijo ali umaknejo, kjer je potrebno, obstoječe registracije za fitofarmacevtska sredstva, ki vsebujejo MCPA ali MCPB kot aktivne snovi.
By that date, they shall in particular verify that the conditions in Annex I to that Directive relating to MCPA and MCPB respectively are met, with the exception of those identified in part B of the entry concerning those active substances, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to that Directive in accordance with the conditions of Article 13.
Do tega datuma zlasti preverijo, da so izpolnjeni pogoji v Prilogi I k navedeni Direktivi v zvezi z MCPA in MCPB, z izjemo tistih, ki so opredeljeni v delu B uvrstitve navedenih aktivnih snovi, in da ima imetnik registracije dokumentacijo ali dostop do dokumentacije, ki izpolnjuje zahteve iz Priloge II k navedeni Direktivi v skladu s pogoji iz člena 13.
By derogation from paragraph 1, for each authorised plant protection product containing MCPA or MCPB as either the only active substance or as one of several active substances all of which were listed in Annex I to Directive 91/414/EEC by 30 April 2006 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles provided for in Annex VI to Directive 91/414/EEC, on the basis of a dossier satisfying the requirements of Annex III to that Directive and taking into account part B of the entry in Annex I to that Directive concerning MCPA and MCPB respectively.
Z odstopanjem od odstavka 1 države članice najpozneje do 30. aprila 2006 ponovno ocenijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje MCPA ali MCPB, bodisi kot edino aktivno snov bodisi kot eno od več aktivnih snovi, ki so navedene v Prilogi I k Direktivi 91/414/EGS, in sicer v skladu z enotnimi načeli iz Priloge VI k Direktivi 91/414/EGS in na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k navedeni direktivi in ob upoštevanju dela B uvrstitve v Prilogi I k Direktivi v zvezi z MCPA in MCPB.
in the case of a product containing MCPA or MCPB as the only active substance, where necessary, amend or withdraw the authorisation by 30 April 2010 at the latest; or
če fitofarmacevtsko sredstvo vsebuje MCPA ali MCPB kot edino aktivno snov, registracijo po potrebi spremenijo ali umaknejo najpozneje do 30. aprila 2010; ali
in the case of a product containing MCPA or MCPB as one of several active substances, where necessary, amend or withdraw the authorisation by 30 April 2010 or by the date fixed for such an amendment or withdrawal in the respective Directive or Directives which added the relevant substance or substances to Annex I to Directive 91/414/EEC, whichever is the latest.
če fitofarmacevtsko sredstvo vsebuje MCPA ali MCPB kot eno od več aktivnih snovi, po potrebi spremenijo ali umaknejo registracijo do 30. aprila 2010 ali do datuma, določenega za tako spremembo ali umik v ustrezni direktivi ali direktivah, v katerih je bila zadevna snov ali so bile zadevne snovi dodane v Prilogo I k Direktivi 91/414/EGS, glede na to, katera je bila zadnja.
This Directive shall enter into force on 1 May 2006.
Ta direktiva začne veljati 1. maja 2006.
Done at Brussels, 21 September 2005.
V Bruslju, 21. septembra 2005
Regulation as last amended by Regulation (EC) No 2266/2000 (OJ L 259, 13.10.2000, p. 10).
Uredba, kakor je bila nazadnje spremenjena z Uredbo (ES) št. 2266/2000 (UL L 259, 13.10.2000, str. 10).
The following entry shall be added at the end of the table in Annex I to Directive 91/414/EEC:
Naslednji vpis se doda na konec tabele v Prilogi I k Direktivi 91/414/ES.
CAS No 94-74-6
CAS št. 94-74-6
CIPAC No 2
CIPAC št. 2
4-chloro-o-tolyloxyacetic acid
4-kloro-o-toliloksi ocetna kislina
1 May 2006
maj 2006
30 April 2016
april 2016
Only uses as herbicide may be authorised
Registrira se lahko samo kot herbicid
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on MCPA, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 15 April 2005 shall be taken into account
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepne ugotovitve poročila o pregledu za MCPA in zlasti dodatkov I in II, kot so bili 15. aprila 2005 dokončno oblikovani v Stalnem odboru za prehransko verigo ljudi in zdravje živali
Member States should pay particular attention to the potential for groundwater contamination, when the active substance is applied in regions with vulnerable soil and/or climatic conditions.
Države članice morajo biti posebno pozorne na možnost onesnaženja podtalnice, ko je aktivna snov uporabljena v regijah z občutljivimi tlemi in/ali podnebnimi razmerami.
Conditions of authorisation should include risk mitigation measures, where appropriate
Pogoji registracije morajo vključevati ukrepe za zmanjšanje tveganja, kadar je to potrebno
Member States must pay particular attention to the protection of aquatic organisms and must ensure that the conditions of authorisation include risk mitigation measures, where appropriate, such as buffer zones
Države članice morajo posebno pozornost posvetiti varovanju vodnih organizmov in morajo zagotoviti, da pogoji registracije vključujejo ukrepe za zmanjšanje tveganja, kjer je potrebno, kot so varovalni pasovi
CAS No 94-81-5
CAS št. 94-81-5
CIPAC No 50
CIPAC št. 50
4-(4-chloro-o-tolyloxy)butyric acid
4-(4-kloro-o-toliloksi)butanojska kislina
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on MCPB, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 15 April 2005 shall be taken into account
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepne ugotovitve poročila o pregledu za MCPB in zlasti dodatkov I in II, kot so bili 15. aprila 2005 dokončno oblikovani v Stalnem odboru za prehransko verigo ljudi in zdravstveno varstvo živali
Member States must pay particular attention to the protection of aquatic organisms and must ensure that the conditions of authorisation include risk mitigation measures, where appropriate, such as buffer zones’
Države članice morajo posebno pozornost posvetiti varovanju vodnih organizmov in morajo zagotoviti, da pogoji registracije vključujejo ukrepe za zmanjšanje tveganja, kjer je potrebno, kot so varovalni pasovi“
Further details on identity and specification of active substance are provided in the review report.
Več podrobnosti o aktivnih snoveh in njihovih lastnostih je v poročilu o pregledu.
Commission Directive 2005/58/EC
Direktiva Komisije 2005/58/ES
amending Council Directive 91/414/EEC to include bifenazate and milbemectin as active substances
o spremembi Direktive Sveta 91/414/EGS zaradi vključitve bifenazata in milbemektina med aktivne snovi
In accordance with Article 6(2) of Directive 91/414/EEC, the Netherlands received on 3 July 2001 an application from Crompton Europe Ltd. for the inclusion of the active substance bifenazate in Annex I to Directive 91/414/EEC.
Nizozemska je 3. julija 2001 prejela v skladu s členom 6(2) Direktive 91/414/EGS zahtevek Crompton Europe Ltd. za vključitev aktivne snovi bifenazat v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2002/268/EC [2] confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Z Odločbo Komisije 2002/268/ES [2] je bilo potrjeno, da je dokumentacija „popolna“, tj. da zanjo načeloma velja, da izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
The Netherlands received an application under Article 6(2) of Directive 91/414/EEC on 6 March 2000 from Sankyo Company Ltd. for the inclusion of the active substance milbemectin in Annex I to Directive 91/414/EEC.
Nizozemska je 6. marca 2000 od Sankyo Company Ltd. prejela vlogo v skladu s členom 6(2) Direktive 91/414/EGS za vključitev aktivne snovi milbemektin v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2000/540/EC [3] confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Z Odločbo Komisije 2000/540/ES [3] je bilo potrjeno, da je dokumentacija „popolna“, tj. da zanjo načeloma velja, da izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
The designated rapporteur Member States submitted draft assessment reports concerning the substances to the Commission on 3 April 2003 (bifenazate) and 16 June 2001 (milbemectin).
Imenovane države članice poročevalke so Komisiji predložile osnutke poročil o oceni, ki se nanašajo na aktivni snovi, in sicer dne 3. aprila 2003 (bifenazat) in dne 16. junija 2001 (milbemektin).
The review was finalised on 3 June 2005 in the format of the Commission review reports for bifenazate and milbemectin.
Pregled je bil dokončno oblikovan 3. junija 2005 v obliki poročil Komisije o pregledu za bifenazat in milbemektin.
The review of bifenazate and milbemectin did not reveal any open questions or concerns, which would have required a consultation of the Scientific Committee on Plants or of the European Food Safety Authority which has taken over the role of that Committee.
Med pregledom bifenazata in milbemektina niso našli nobenih odprtih vprašanj ali razlogov za zaskrbljenost, ki bi zahtevali posvetovanje z Znanstvenim odborom za rastline ali Evropsko agencijo za varnost hrane, ki je prevzela vlogo navedenega odbora.
It has appeared from the various examinations made that plant protection products containing the active substances concerned may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) and Article 5(3) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review report.
Različne opravljene preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo katero koli od zadevnih aktivnih snovi, lahko pričakuje, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) in člena 5(3) Direktive 91/414/EGS, zlasti glede uporab, ki so bile preučene in podrobno navedene v poročilih Komisije o pregledu.
It is therefore appropriate to include bifenazate and milbemectin in Annex I, in order to ensure that in all Member States the authorisations of plant protection products containing these active substances may be granted in accordance with the provisions of that Directive.
Zato je primerno, da se bifenazat in milbemektin vključita v Prilogo I, da se lahko v vseh državah članicah zagotovi odobritev registracije fitofarmacevtskih sredstev, ki vsebujejo ti aktivni snovi, v skladu z določbami navedene direktive.